Autoimmune pancreatitis diagnostic study of choice
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]
Overview
Overview
Autoimmune pancreatitis is diagnosed by revised HISORt criteria, proposed by Mayo clinic, that includes histology, pancreatic imaging, serology, other organ involvement, and response to steroid treatment.
Diagnostic Study of Choice
Diagnostic Study of Choice
Diagnostic Criteria
Autoimmune pancreatitis is diagnosed by revised HISORt criteria, proposed by Mayo clinic and may include one or more of the following:[1][2]
| Criteria | |
|---|---|
| (H) | Histology suggestive of autoimmine pancreatitis |
| (I) | Pancreatic imaging suggestive of autoimmune pancreatitis |
| (S) | Serology (IgG4 ≥2 times the upper limit of normal) |
| (O) | Other organ involvement
|
| (Rt) | Response to steroid treatment |
References
References
- ↑ Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, Petersen BT, Topazian MA, Vege SS (2009). “A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer”. Clin. Gastroenterol. Hepatol. 7 (10): 1097–103. doi:10.1016/j.cgh.2009.04.020. PMID 19410017.
- ↑ Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB (2006). “Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience”. Clin. Gastroenterol. Hepatol. 4 (8): 1010–6, quiz 934. doi:10.1016/j.cgh.2006.05.017. PMID 16843735.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH